For: | Jiang L, Yan LN. Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol 2010; 16(20): 2468-2475 [PMID: 20503446 DOI: 10.3748/wjg.v16.i20.2468] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i20/2468.htm |
Number | Citing Articles |
1 |
Elin Teppa, Francesca Nadalin, Christophe Combet, Diego Javier Zea, Laurent David, Alessandra Carbone. Coevolution analysis of amino-acids reveals diversified drug-resistance solutions in viral sequences: a case study of hepatitis B virus. Virus Evolution 2020; 6(1) doi: 10.1093/ve/veaa006
|
2 |
Anthony S. Robbins, Derrick D. Cox, Lynt B. Johnson, Elizabeth M. Ward. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007. Cancer 2011; 117(19): 4531 doi: 10.1002/cncr.26063
|
3 |
Andres F. Carrion, Paul Martin, Christopher O’Brien. Management of Patients with Chronic Hepatitis B Before and After Liver Transplantation: An Update. Current Hepatitis Reports 2012; 11(2): 102 doi: 10.1007/s11901-012-0128-4
|
4 |
Marie A. Laryea, Kymberly D. Watt. Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation. Liver Transplantation 2012; 18(5): 514 doi: 10.1002/lt.23408
|
5 |
Allan GN Angus, Arvind H Patel. Immunotherapeutic Potential Of Neutralizing Antibodies Targeting Conserved Regions Of The HCV Envelope Glycoprotein E2. Future Microbiology 2011; 6(3): 279 doi: 10.2217/fmb.11.9
|
6 |
Yin‐jie Gao, Min Zhang, Bo Jin, Fan‐ping Meng, Xue‐mei Ma, Zhen‐wen Liu, Hai‐bin Su, Jing‐min Zhao, Han‐wei Li. A clinical‐pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients. Journal of Gastroenterology and Hepatology 2014; 29(3): 554 doi: 10.1111/jgh.12404
|
7 |
Shu-Shan Zhao, Lan-Hua Tang, Xia-Hong Dai, Wei Wang, Rong-Rong Zhou, Li-Zhang Chen, Xue-Gong Fan. Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: A Systematic Review. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-111
|
8 |
Guang-Qin Xiao, Jia-Yin Yang, Lu-Nan Yan. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2015; 14(6): 588 doi: 10.1016/S1499-3872(15)60416-7
|
9 |
Haripriya Maddur, Josh Levitsky. Schiff's Diseases of the Liver. 2017; : 1127 doi: 10.1002/9781119251316.ch46
|
10 |
Kymberly D. S. Watt, Marie A. Laryea. Schiff's Diseases of the Liver. 2011; : 1152 doi: 10.1002/9781119950509.ch47
|
11 |
Ramin Raul Ossami Saidy, Franziska Eurich, Maximilian Paul Postel, Eva Maria Dobrindt, Jasper Feldkamp, Selina Johanna Schaper, Johann Pratschke, Brigitta Globke, Dennis Eurich. Clinical and Histological Long-Term Follow-Up of De Novo HBV-Infection after Liver Transplantation. Medicina 2021; 57(8): 767 doi: 10.3390/medicina57080767
|
12 |
Guang-Qin Xiao, Jiu-Lin Song, Shu Shen, Jia-Yin Yang, Lu-Nan Yan. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation. World Journal of Gastroenterology 2014; 20(31): 10953-10959 doi: 10.3748/wjg.v20.i31.10953
|
13 |
Matthew S. Chang, Robert S. Brown. Hepatitis B and Liver Transplantation: Update in Management before and after Transplantation. Current Hepatitis Reports 2011; 10(4): 255 doi: 10.1007/s11901-011-0108-0
|